Ubiquitin ligase E3 HUWE1/MULE targets transferrin receptor for degradation and suppresses ferroptosis in acute liver injury-Reference-Cited by-同舟云学术

Ubiquitin ligase E3 HUWE1/MULE targets transferrin receptor for degradation and suppresses ferroptosis in acute liver injury

Published:2022-03-08 Issue:9 Volume:29 Page:1705-1718
ISSN:1350-9047
Container-title:Cell Death & Differentiation
language:en
Short-container-title:Cell Death Differ

Author:

Wu Yan,Jiao Huike,Yue Yangbo^ORCID,He Kang^ORCID,Jin Yuting,Zhang Jiang,Zhang Jing,Wei Yuehan,Luo Hanyan,Hao Zhenyue,Zhao Xuyun,Xia Qiang^ORCID,Zhong Qing^ORCID,Zhang Jing

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

https://www.nature.com/articles/s41418-022-00957-6.pdf

Reference55 articles.

1. Zhai Y, Busuttil RW, Kupiec-Weglinski JW. Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am J Transpl. 2011;11:1563–9.

2. Peralta C, Jimenez-Castro MB, Gracia-Sancho J. Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu. J Hepatol. 2013;59:1094–106.

3. Guicciardi ME, Malhi H, Mott JL, Gores GJ. Apoptosis and necrosis in the liver. Compr Physiol. 2013;3:977–1010.

4. Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060–72.

5. Conrad M, Angeli JP, Vandenabeele P, Stockwell BR. Regulated necrosis: disease relevance and therapeutic opportunities. Nat Rev Drug Discov. 2016;15:348–66.

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and validation of ferroptosis-related hub genes and immune infiltration in liver ischemia-reperfusion injury;Genomics;2024-09

2. Protein modification and degradation in ferroptosis;Redox Biology;2024-09

3. The involvement of the Stat1/Nrf2 pathway in exacerbating Crizotinib-induced liver injury: implications for ferroptosis;Cell Death & Disease;2024-08-19

4. Ferroptosis-based advanced therapies as treatment approaches for metabolic and cardiovascular diseases;Cell Death & Differentiation;2024-07-27

5. Discovery of a NCOA4 Degrader for Labile Iron-Dependent Ferroptosis Inhibition;Journal of Medicinal Chemistry;2024-07-24